DESANTIS, VANESSA
 Distribuzione geografica
Continente #
NA - Nord America 1.425
EU - Europa 338
AS - Asia 191
AF - Africa 5
SA - Sud America 2
OC - Oceania 1
Totale 1.962
Nazione #
US - Stati Uniti d'America 1.424
SE - Svezia 127
CN - Cina 121
IT - Italia 99
SG - Singapore 32
DE - Germania 24
GB - Regno Unito 23
FR - Francia 18
VN - Vietnam 17
FI - Finlandia 15
IN - India 9
BE - Belgio 5
ES - Italia 4
HK - Hong Kong 4
CH - Svizzera 3
EG - Egitto 3
IE - Irlanda 3
KR - Corea 3
NL - Olanda 3
UA - Ucraina 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
IR - Iran 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BY - Bielorussia 1
CA - Canada 1
CL - Cile 1
EE - Estonia 1
IL - Israele 1
LU - Lussemburgo 1
NO - Norvegia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
VE - Venezuela 1
Totale 1.962
Città #
Chandler 222
Fairfield 172
Ashburn 131
Woodbridge 130
Nyköping 120
Cambridge 81
Seattle 78
New York 69
Houston 65
Wilmington 65
Ann Arbor 60
Bari 42
Beijing 37
Lawrence 27
Roxbury 26
Dearborn 19
Nanjing 19
Inglewood 18
Des Moines 17
Dong Ket 17
Singapore 17
Rome 14
Marseille 11
San Diego 11
Grafing 10
Helsinki 9
Los Angeles 9
Brooklyn 8
Princeton 8
Washington 8
Hebei 7
London 7
Munich 7
Guangzhou 6
Brussels 5
Jacksonville 5
Paris 5
Pune 5
Brescia 4
Rotherham 4
Tianjin 4
Boardman 3
Changsha 3
Dublin 3
Geneva 3
Grumo Appula 3
Jiaxing 3
Jinan 3
Lodi 3
Nanchang 3
Ningbo 3
Redwood City 3
Suri 3
Wuxi 3
Al Mansurah 2
Alcorcón 2
Ardabil 2
Augusta 2
Aversa 2
Brno 2
Chicago 2
Guro-gu 2
Hefei 2
Hong Kong 2
Las Rozas de Madrid 2
Leverano 2
New Bedfont 2
New Haven 2
Padova 2
Shenyang 2
Shenzhen 2
Acton 1
Amsterdam 1
Arzano 1
Baotou 1
Barletta 1
Bratislava 1
Buk-gu 1
Chiswick 1
Clifton 1
Copenhagen 1
Dubai 1
Durham 1
Giza 1
Graz 1
Gurgaon 1
Hangzhou 1
Kilburn 1
Kunming 1
Kyiv 1
Las Vegas 1
Leipzig 1
Lequile 1
Luxembourg 1
Manisa 1
Markham 1
Mestre 1
Minsk 1
Modugno 1
Radeberg 1
Totale 1.681
Nome #
Isolation and characterization of neural stem cells from dystrophic mdx mouse 134
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 120
Microenvironment drug resistance in multiple myeloma: Emerging new players 119
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 115
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 101
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 94
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 93
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 91
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 88
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 84
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 83
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 82
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 78
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 75
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance” 68
Erratum: Corrigendum to “Isolation and characterization of neural stem cells from dystrophic mdx mouse” (Experimental Cell Research (2016) 343(1) (190–207) (S0014482716300593) (10.1016/j.yexcr.2016.03.019)) 64
“miRNAs profile of bone marrow fibroblasts in multiple myeloma: relationship with disease progression and drug-resistance” 57
The role of SIRT6 in tumors 54
null 43
null 39
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 37
Diabetes and alzheimer’s disease: Might mitochondrial dysfunction help deciphering the common path? 36
Myeloma cells regulate {miRNA} transfer from fibroblast-derived exosomes by expression of {lncRNAs} 32
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 29
Antiangiogenic drugs as chemosensitizers in hematological tumors 28
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 24
FGF trapping inhibits multiple myeloma growth through c-Myc degradation–induced mitochondrial oxidative stress 24
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 23
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 23
A Challenging Case of Visceral Leishmaniasis 22
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 22
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 21
Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, ex vivo and in vitro Analysis 20
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion 20
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure 15
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 12
microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation 12
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 10
Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression 10
Targeting the immune microenvironment in Waldenström Macroglobulinemia via halting the CD40/CD40-ligand axis 9
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 7
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 7
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 7
The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value 6
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 6
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study 5
Correlation between atrial cardiomyopathy and predictive biomarkers of cryptogenic stroke in primary and secondary prophylaxis: potential role of endothelial progenitor cell (EPCs) dysfunction 4
Mast Cells and Interleukins 3
Changes in Lipids in Granulomatosis with Polyangiitis Relates to Glucocorticoids and History of Hypertension 2
Epigenetic regulation of angiogenesis in tumor progression 2
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects 2
Visualizing the Interactions Shaping the Imaging of the Microenvironment in Human Cancers 1
Navigating Lymphomas through BCR Signaling and Double-Hit Insights: Overview 1
The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic Developments 1
Totale 2.165
Categoria #
all - tutte 11.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.411


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020362 0 14 11 30 34 40 49 48 51 34 37 14
2020/2021410 9 16 19 24 84 29 47 33 30 56 29 34
2021/2022252 11 18 4 10 8 17 14 11 19 26 38 76
2022/2023482 44 83 40 49 41 66 9 58 69 10 11 2
2023/2024289 20 27 18 23 32 109 7 12 0 17 6 18
2024/202575 51 24 0 0 0 0 0 0 0 0 0 0
Totale 2.165